<DOC>
	<DOCNO>NCT02775929</DOCNO>
	<brief_summary>The purpose protocol determine user preference antiretroviral therapy ( ART ) HIV-1 infected partner pre-exposure prophylaxis ( PrEP ) HIV-1 un-infected partner optimize targeted delivery sustain use intervention .</brief_summary>
	<brief_title>Partners Demonstration Project PrEP ART</brief_title>
	<detailed_description>An open-label , prospective cohort study higher-risk HIV-1 serodiscordant couple order determine barrier facilitator uptake sustain adherence ART HIV-1 infected partner daily oral PrEP HIV-1 uninfected partner . The investigator develop risk score tool identify couple high risk HIV-1 transmission . PrEP offer 'bridge ' ART partnership - i.e. , ART initiation HIV-infected partner first 6 month ART start ; ART recommend follow national ART guideline . A subset ( 80 couple per site ) invite participate qualitative in-depth interview focus group discussion .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>For couple Risk score define high HIV1 risk ( ≥6 ) Sexually active ( defined vaginal intercourse least 6 time previous three month ) Willing enter study couple intend remain couple next 12 month Did participate Partners PrEP Study For HIV1 uninfected member couple ( partner participant ) Age ≥18 Able willing provide write informed consent HIV1 uninfected base negative HIV1 rapid test , study screen enrollment visit Adequate renal function , define normal creatinine level estimate creatinine clearance &gt; 60 mL/min Not infect hepatitis B virus , determine negative hepatitis B surface antigen test Not currently pregnant breastfeed Not currently enrol HIV1 prevention clinical trial Not currently use PrEP Enrollment individual active serious infection active clinically significant medical problem discretion site investigator For HIV1 infect member couple ( index participant ) Age ≥18 Able willing provide write informed consent HIV1 infect base positive rapid HIV1 test , accord national algorithm No history WHO stage III IV condition Not currently use ART Not currently enrol HIV1 treatment study Note : current pregnancy breastfeeding permit HIV1 infect partner Otherwise eligible base inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Tenofovir disoproxil</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Pre-exposure Prophylaxis</keyword>
	<keyword>Antiretroviral Therapy</keyword>
	<keyword>HIV Prevention</keyword>
	<keyword>FTC TDF</keyword>
	<keyword>PrEP</keyword>
	<keyword>HIV Infected Partners</keyword>
	<keyword>HIV Uninfected Partners</keyword>
</DOC>